Philip L S M Gordts

8PUBLICATIONS
36CO-AUTHORS
HaematologyFood properties (incl. characteristics and health benefits)Epigenetics (incl. genome methylation and epigenomics)GlycoconjugatesNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 03, 2025
LDL-Bound PCSK9 Has a Slower Clearance Kinetic and Higher Use for HSPGs Than Free-PCSK9-Brief Report.

Silvia Cecilia Pacheco-Velázquez, Carlota Oleaga, Bastian Ramms

|Aug 01, 2024
Time-Restricted Feeding Reduces Atherosclerosis in LDLR KO Mice but Not in ApoE Knockout Mice.

Amandine Chaix, Terry Lin, Bastian Ramms

|Mar 31, 2022
Author Correction: Genome-wide screens uncover KDM2B as a modifier of protein binding to heparan sulfate.

Ryan J Weiss, Philipp N Spahn, Austin W T Chiang

|Sep 30, 2021
Dietary Neu5Ac Intervention Protects Against Atherosclerosis Associated With Human-Like Neu5Gc Loss-Brief Report.

Kunio Kawanishi, Joanna K Coker, Kaare V Grunddal

|Apr 13, 2021
Genome-wide screens uncover KDM2B as a modifier of protein binding to heparan sulfate.

Ryan J Weiss, Philipp N Spahn, Austin W T Chiang

|Apr 12, 2020
ZNF263 is a transcriptional regulator of heparin and heparan sulfate biosynthesis.

Ryan J Weiss, Philipp N Spahn, Alejandro Gómez Toledo

Pageof 2